MAPS Annual Financial Report
	Fiscal Year 2003-2004	June 1, 2003 - May 31, 2004
	Introduction
	The basic balance sheet information for FY 2003-2004 is presented below. MAPS IRS Form 990 for 2004 is available in PDF format.
	Income
	MAPS total income for FY 2003-2004 was $1,035,873.
	Expenses
	Total expenses were $653,780, which resulted in an increase of assets in the amount of $382,093. Of these expenses, project expenses totaled $413,266 and operational costs were $229,222. A chart of all of MAPS expenses for FY 2003-2004 is available in PDF format.
	Assets
	Total assets at the end of FY 2002-2003 were $761,496. Of these assets, restricted funds amounted to $456,800 and unrestricted funds amounted to $304,700. Of the restricted funds $82,560 was for MDMA/PTSD research, $206,690 was for the overall MDMA Psychotherapy Research Effort, $1,500 for Ecstasy Pill Testing, $13,000 for the Vaporizer Study, $50,000 for the Harvard LSD/Psilocybin/Cluster Headache Study, $102,000 for the Project Start-Up Fund: UMass Amherst, and $1000 for the Creativity Study.
	Comparative results
	A chart presenting comparative results for the financial years 2000 - 2004 is available in PDF format.